Database Locked for the Rare Disease Pediatric Study
GCT team is proud for taking part in achievement of the major milestone for the Phase III clinical trial.
The study is being successfully conducted, amidst the present difficult global environment, in pediatric patients suffering from a rare neurological disease. In January 2020, GCT has successfully completed the enrollment of patients in Russia. We have now reached the next milestone – the Database Lock.
September 7, 2020
Multiple Sclerosis Observational Study in Georgia
Global Clinical Trials is managing its first local project in Georgia. It is a recently awarded observational Phase IV clinical trial in Multiple Sclerosis.
GCT team is performing local management of the multinational study sponsored by an international Big Pharma. It includes trainings, regulatory documentation handling, adjustment and submission of amendments, site monitoring and close-out, and the eTMF maintenance.
September 1, 2020
New Phase I Breast Cancer Study Awarded in Russia
GCT has been awarded a new Phase I clinical trial in patients with breast cancer. It aims to prove the safety, tolerance and pharmacokinetics of the Investigated Medical Product (IMP) using the dose escalation method. The study will be conducted in Russia with enrolling 60 patients who suffer from palindromic or refractory metastatic breast cancer. The project is sponsored by a Russian biotechnology start-up company specializing in oncology research.
August 3, 2020
Chronic Pancreatitis Study: First Patient In
GCT is proud to announce successful enrollment of the first patient in Russia in the Chronic Pancreatitis clinical trial. The multinational Phase II randomized double-blind Gastroenterology trial is aiming to enroll over 160 patients in total. GCT is managing the study in Russia and Ukraine and covering the full-service clinical support.
July 15, 2020
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
